UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 105

Sortiert nach

Outcome of Children With Metastatic Medulloblastoma Treated With Carboplatin During Craniospinal Radiotherapy: A Children's Oncology Group Phase I/II Study

Journal of clinical oncology, 2012-07, Vol.30 (21), p.2648-2653

2012

Link zum Volltext

Verfügbarkeit prüfen

Magnetic Resonance Spectroscopy Metabolites as Biomarkers of Disease Status in Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG) Treated with Glioma-Associated Antigen Peptide Vaccines

Cancers, 2022-12, Vol.14 (23), p.5995

2022

Link zum Volltext

Verfügbarkeit prüfen

IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group

Child's nervous system, 2011-01, Vol.27 (1), p.87-94

2011

Link zum Volltext

Verfügbarkeit prüfen

Motexafin-Gadolinium and Involved Field Radiation Therapy for Intrinsic Pontine Glioma of Childhood: A Children's Oncology Group Phase 2 Study

International journal of radiation oncology, biology, physics, 2013, Vol.85 (1), p.e55-e60

2013

Link zum Volltext

Verfügbarkeit prüfen

Pseudoprogression of low-grade gliomas after radiotherapy

Pediatric blood & cancer, 2015-01, Vol.62 (1), p.35-39

2015

Link zum Volltext

Verfügbarkeit prüfen

Pediatric Phase I and Pharmacokinetic Study of Erlotinib Followed by the Combination of Erlotinib and Temozolomide: A Children's Oncology Group Phase I Consortium Study

Journal of clinical oncology, 2008-10, Vol.26 (30), p.4921-4927

2008

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas

Pediatric blood & cancer, 2015-02, Vol.62 (2), p.240-245

2015

Link zum Volltext

Verfügbarkeit prüfen

Quantitative Sodium ( 23 Na) MRI in Pediatric Gliomas: Initial Experience

Diagnostics (Basel), 2022-05, Vol.12 (5), p.1223

2022

Link zum Volltext

Verfügbarkeit prüfen

Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial

The lancet oncology, 2019-07, Vol.20 (7), p.1011-1022

2019

Link zum Volltext

Verfügbarkeit prüfen

Childhood brain tumors: epidemiology, current management and future directions

Nature reviews. Neurology, 2011-09, Vol.7 (9), p.495

2011

Link zum Volltext

Verfügbarkeit prüfen

Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas

Journal of clinical oncology, 2014-07, Vol.32 (19), p.2050-2058

2014

Link zum Volltext

Verfügbarkeit prüfen

Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab

JAMA ophthalmology, 2014-01, Vol.132 (1), p.111

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study

Neuro-oncology (Charlottesville, Va.), 2016-10, Vol.18 (10), p.1442-1450

2016

Link zum Volltext

Verfügbarkeit prüfen

Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children’s Oncology Group

Journal of neuro-oncology, 2010-09, Vol.99 (2), p.155-163

2010

Link zum Volltext

Verfügbarkeit prüfen

Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas

Pediatric blood & cancer, 2013-05, Vol.60 (5), p.776-782

2013

Link zum Volltext

Verfügbarkeit prüfen

Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomas

Neuro-oncology (Charlottesville, Va.), 2016-08, Vol.18 (8), p.1157-1168

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report

Neuro-oncology (Charlottesville, Va.), 2020-11, Vol.22 (11), p.1696-1704

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas

Neuro-oncology (Charlottesville, Va.), 2017-02, Vol.19 (2), p.289-297

2017

Link zum Volltext

Verfügbarkeit prüfen

Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study

Journal of neuro-oncology, 2016-12, Vol.130 (3), p.517-527

2016

Link zum Volltext

Verfügbarkeit prüfen

Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: A report from the children's oncology group

Pediatric blood & cancer, 2010-12, Vol.55 (6), p.1066-1071

2010

Link zum Volltext

Verfügbarkeit prüfen

LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma

Clinical cancer research, 2013-04, Vol.19 (7), p.1816-1826

2013

Link zum Volltext

Verfügbarkeit prüfen

Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: A report from the Children's Oncology Group

Pediatric blood & cancer, 2015-05, Vol.62 (5), p.776-783

2015

Link zum Volltext

Verfügbarkeit prüfen

Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study

Journal of neuro-oncology, 2016-08, Vol.129 (1), p.131-138

2016

Link zum Volltext

Verfügbarkeit prüfen

Peptide Vaccine Therapy for Childhood Gliomas

Neurosurgery, 2013-08, Vol.60 (CN_suppl_1), p.113-119

2013

Link zum Volltext

Verfügbarkeit prüfen

Increased expression of tumor-associated antigens in pediatric and adult ependymomas: implication for vaccine therapy

Journal of neuro-oncology, 2013-01, Vol.111 (2), p.103-111

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(95)

Publikationsform

Artikel
(103)
Buchkapitel
(2)

Sprache

Englisch
(105)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Humans
(79)
Life Sciences & Biomedicine
(74)
Science & Technology
(74)
Child
(64)
Male
(58)
Oncology
(57)
Adolescent
(54)
Child, Preschool
(54)
Female
(52)
Biological And Medical Sciences
(35)
Medical Sciences
(35)
Infant
(33)
Pediatrics
(32)
Adult
(24)
Clinical Neurology
(24)
Neurosciences & Neurology
(24)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)
Brain Neoplasms - Drug Therapy
(22)
Chemotherapy
(20)
Glioma - Drug Therapy
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Outcome of Children With Metastatic Medulloblastoma Treated With Carboplatin During Craniospinal Radiotherapy: A Children's Oncology Group Phase I/II Study

Magnetic Resonance Spectroscopy Metabolites as Biomarkers of Disease Status in Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG) Treated with Glioma-Associated Antigen Peptide Vaccines

IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group

Motexafin-Gadolinium and Involved Field Radiation Therapy for Intrinsic Pontine Glioma of Childhood: A Children's Oncology Group Phase 2 Study

Pseudoprogression of low-grade gliomas after radiotherapy

Pediatric Phase I and Pharmacokinetic Study of Erlotinib Followed by the Combination of Erlotinib and Temozolomide: A Children's Oncology Group Phase I Consortium Study

Bevacizumab for symptomatic radiation-induced tumor enlargement in pediatric low grade gliomas

Quantitative Sodium ( 23 Na) MRI in Pediatric Gliomas: Initial Experience

Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial

Childhood brain tumors: epidemiology, current management and future directions

Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas

Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab

Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study

Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children’s Oncology Group

Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas

Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomas

Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report

Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas

Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study

Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: A report from the children's oncology group

LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma

Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: A report from the Children's Oncology Group

Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study

Peptide Vaccine Therapy for Childhood Gliomas

Increased expression of tumor-associated antigens in pediatric and adult ependymomas: implication for vaccine therapy

Suchergebnisse filtern